Suscribirse

Advances in stimuli-responsive gold nanorods for drug-delivery and targeted therapy systems - 08/11/24

Doi : 10.1016/j.biopha.2024.117493 
Sakineh Hajebi a, b, 1, Mohsen Chamanara a, b, 1, Shadi Sadat Nasiri c, Mahsa Ghasri d, Alireza Mouraki e, Reza Heidari f, g, h, , 2 , Abbas Nourmohammadi i, j,
a Toxicology Research Center, AJA University of Medical Sciences, Tehran, Iran 
b Biomaterial and Medicinal Chemistry Research Center, AJA University of Medical Science, Tehran, Iran 
c Department of Polymer Engineering and Color Technology, Amirkabir University of Technology, Tehran, Iran 
d Adhesive and Resin Department, Polymer Processing Faculty, Iran Polymer and Petrochemical Institute (IPPI), Tehran, Iran 
e Department of Surface Coating and Corrosion, Institute for Color Science and Technology, Tehran, Iran 
f Cancer Epidemiology Research Center (AJA-CERTC), AJA University of Medical Sciences, Tehran, Iran 
g Medical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, Iran 
h Biomaterial and Medicinal Chemistry Research Center, AJA University of Medical Science, Tehran, Iran 
i Clinical Biomechanics and Ergonomics Research Center, AJA University of Medical Sciences, Tehran, Iran 
j Research Center of Aerospace Medicine, AJA University of Medical Sciences, Tehran, Iran 

Corresponding author at:Cancer Epidemiology Research Center (AJA-CERTC), AJA University of Medical Sciences, Tehran, Iran.Cancer Epidemiology Research Center (AJA-CERTC), AJA University of Medical SciencesTehranIran⁎⁎Corresponding author at: Clinical Biomechanics and Ergonomics Research Center, AJA University of Medical Sciences, Tehran, Iran.Clinical Biomechanics and Ergonomics Research Center, AJA University of Medical SciencesTehranIran

Abstract

In recent years, the use of gold nanorods (AuNRs) has garnered considerable attention in biomedical applications due to their unique optical and physicochemical properties. They have been considered as potential tools for the advanced treatment of diseases by various stimuli such as magnetic fields, pH, temperature and light in the fields of targeted therapy, imaging and drug delivery. Their biocompatibility and tunable plasmonic properties make them a versatile platform for a range of biomedical applications. While endogenous stimuli have limited cargo delivery control at specific sites, exogenous stimuli are a more favored approach despite their circumscribed penetration depth for releasing the cargo at the specific target. Dual/multi-stimuli responsive AuNTs can be triggered by multiple stimuli for enhanced control and specificity in biomedical applications. This review provides to provide a summary of the biomedical applications of stimuli-responsive AuNRs, including their endogenous and exogenous properties, as well as their dual/multi-functionality and potential for clinical delivery. This review provides a comprehensive review on the improvement of therapeutic efficacy and the effective control of drug release with AuNRs, highlights AuNRs design strategies in recent years, discusses the advantages or challenges so far in the field of AuNRs. Finally, we have addressed the clinical translation bio-integrated nanoassemblies (CTBNs) in this field.

El texto completo de este artículo está disponible en PDF.

Graphical Abstract




El texto completo de este artículo está disponible en PDF.

Highlights

This review summarizes the recent advances in stimuli-responsive gold nanorods.
The combination of chemotherapy and PTT results in complete breast cancer tumor suppression without systemic toxicity.
Gold nanoparticles, activated by external stimuli like magnetic fields, light, or ultrasound, generate heat for hyperthermia treatments.
The drug-delivery, targeting and diagnostic applications of the gold nanorods are addressed.
Recent advances in stimuli-responsive gold nanorods are reviewed.

El texto completo de este artículo está disponible en PDF.

Keywords : Gold nanorods, Stimuli-responsive, Endogenous stimuli, Exogenous stimuli, Drug delivery, Biomedical applications


Esquema


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 180

Artículo 117493- novembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Research advances in signaling pathways related to the malignant progression of HSIL to invasive cervical cancer: A review
  • Huifang Wang, Chang Liu, Keer Jin, Xiang Li, Jiaxin Zheng, Danbo Wang
| Artículo siguiente Artículo siguiente
  • Dysbiosis and diabetic foot ulcers: A metabolic perspective of Staphylococcus aureus infection
  • Ruisi Liu, Jiawei Feng, Yiming Ni, Kaixin Chen, Yuqing Wang, Ting Zhang, Mingmei Zhou, Cheng Zhao

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.